(Q34554560)

English

HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1 reference

Europe PubMed Central

HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

anti-retroviral agent

0 references

1 reference

based on heuristic

inferred from title

9

object named as

Jens Lundgren

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Antonella d'Arminio Monforte

14

object named as

Antonella d'Arminio Monforte

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Gerd Fätkenheuer

12

object named as

Gerd Fätkenheuer

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Dominique Costagliola

3

object named as

Dominique Costagliola

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Schlomo Staszewski

13

object named as

Schlomo Staszewski

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

object named as

Caroline A Sabin

4

0 references

François Dabis

7

object named as

François Dabis

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

10

object named as

Robert S Hogg

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Andrew N Phillips

5

object named as

Andrew N Phillips

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

6

object named as

Amy C Justice

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Jonathan Sterne

2

object named as

Jonathan A C Sterne

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

author name string

John Gill

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Frank de Wolf

11

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Matthias Egger

15

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Antiretroviral Therapy (ART) Cohort Collaboration

16

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

language of work or name

0 references

publication date

1 August 2006

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

368

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

9534

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

451-458

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Physician specialization and the quality of care for human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of complete resistance to at least two classes of antiretroviral drugs in treated HIV-1-infected patients: a French nationwide study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Deaths in the era of HAART: contribution of late presentation, treatment exposure, resistance and abnormal laboratory markers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Development and validation of a prognostic model for survival time data: application to prognosis of HIV positive patients treated with antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic model for HIV-1 disease progression in patients starting antiretroviral therapy was validated using independent data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical Outcome of Patients with HIV-1 Infection according to Immunologic and Virologic Response after 6 Months of Highly Active Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Modeling changes in CD4-positive T-lymphocyte counts after the start of highly active antiretroviral therapy and the relation with risk of opportunistic infections: the Aquitaine Cohort, 1996-1997

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Regional differences in use of antiretroviral agents and primary prophylaxis in 3122 European HIV-infected patients. EuroSIDA Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Zidovudine and stavudine sequencing in HIV treatment planning: findings from the CHORUS HIV cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The changing pattern of admissions to a London hospital of patients with HIV: 1988-1997. Royal Free Centre for HIV Medicine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of a viral response and subsequent virological treatment failure in patients with HIV starting a protease inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Migration and HIV epidemic in Greece

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiological changes in AIDS and HIV infection in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Foci of tuberculosis transmission in central Los Angeles

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Decline in the AIDS and death rates in the EuroSIDA study: an observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes Over Time in Risk of Initial Virological Failure of Combination Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Newly diagnosed HIV infections: review in UK and Ireland

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Expanded screening for HIV in the United States--an analysis of cost-effectiveness.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969152-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(06)69152-6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34554560&oldid=1750894821"